Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 0.92B P/E 12.50 EPS this Y -22.50% Ern Qtrly Grth -20.00%
Income 74.36M Forward P/E 11.72 EPS next Y 5.20% 50D Avg Chg 8.00%
Sales 1.08B PEG 0.86 EPS past 5Y 24.95% 200D Avg Chg 19.00%
Dividend 1.00% Price/Book 1.86 EPS next 5Y 15.00% 52W High Chg -2.00%
Recommedations 1.50 Quick Ratio 1.43 Shares Outstanding 47.25M 52W Low Chg 56.00%
Insider Own 0.81% ROA 6.27% Shares Float 41.99M Beta 1.28
Inst Own 83.87% ROE 13.28% Shares Shorted/Prior 2.14M/3.02M Price 28.00
Gross Margin 24.84% Profit Margin 6.88% Avg. Volume 146,414 Target Price 38.75
Oper. Margin 8.36% Earnings Date Dec 12 Volume 80,161 Change -1.06%
About Quanex Building Products Corpor

Quanex Building Products Corporation, together with its subsidiaries, provides components for the fenestration industry in the United States, rest of Europe, Canada, Asia, the United Kingdom, and internationally. The company operates through three segments: North American Fenestration, European Fenestration, and North American Cabinet Components. It offers flexible insulating glass spacers, extruded vinyl profiles, window and door screens, and precision-formed metal and wood products, as well as cabinet doors and other components for original equipment manufacturers (OEMs) in the kitchen and bathroom cabinet industry. In addition, the company provides various non-fenestration components and products, including solar panel sealants, trim moldings, vinyl decking, fencing, water retention barriers, and conservatory roof components. It sells its products to OEMs in the building products industry through sales representatives, direct sales force, distributors, and independent sales agents. Quanex Building Products Corporation was founded in 1927 and is based in Houston, Texas.

Quanex Building Products Corpor News
11/13/24 M-tron Industries, Inc. (MPTI) Q3 Earnings and Revenues Surpass Estimates
10/28/24 Quanex Building Products Corporation (NYSE:NX) is favoured by institutional owners who hold 79% of the company
10/14/24 Quanex Building Products' (NYSE:NX) investors will be pleased with their notable 62% return over the last five years
09/29/24 The Return Trends At Quanex Building Products (NYSE:NX) Look Promising
09/12/24 Quanex Building Products Corporation (NYSE:NX) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
09/11/24 Q2 Earnings Outperformers: Quanex (NYSE:NX) And The Rest Of The Home Construction Materials Stocks
09/07/24 Quanex Building Products Third Quarter 2024 Earnings: EPS Beats Expectations
09/07/24 Q3 2024 Quanex Building Products Corp Earnings Call
09/06/24 Why Quanex (NX) Stock Is Up Today
09/06/24 Quanex's Stock Up on Q3 Earnings & Sales Beat, Margins Down Y/Y
09/06/24 Why Quanex Building Products Stock Is Climbing Today
09/05/24 Quanex Building Products (NX) Q3 Earnings and Revenues Beat Estimates
09/05/24 Quanex (NYSE:NX) Posts Q2 Sales In Line With Estimates, Stock Jumps 19.1%
09/05/24 Quanex: Fiscal Q3 Earnings Snapshot
09/05/24 Quanex Building Products Announces Third Quarter 2024 Results and Updates Full Year 2024 Guidance
09/05/24 Armstrong World Stock Rises 26% YTD: What's Next for Investors?
09/05/24 Quanex Building Products (NYSE:NX) Has Announced A Dividend Of $0.08
09/04/24 Quanex (NX) To Report Earnings Tomorrow: Here Is What To Expect
09/03/24 Should You Investigate Quanex Building Products Corporation (NYSE:NX) At US$27.63?
09/02/24 Quanex Gears Up to Report Q3 Earnings: What's in the Offing?
NX Chatroom

User Image Estimize Posted - 6 days ago

Wall St is expecting 0.56 EPS for $NX Q4 [Reporting 12/12 AMC] http://www.estimize.com/intro/nx?chart=historical&metric_name=eps&utm_conten

User Image swingingtech Posted - 10/20/24

$NEXE $NEXNF $NX https://wallstreetwaves.com/nexe-innovations-shares-key-developments-and-progress-update/

User Image Grouphome Posted - 09/21/24

$NX monthly

User Image StockInvest_us Posted - 1 month ago

Signal alert: $NX - PivotPoint bottom https://stockinvest.us/l/wvQcnGMxXs

User Image intratio Posted - 2 months ago

$NX The trained A.I judges that this company s value has a poor setup for the immediate future and the stock price is consistent with the company s long-term fundamentals

User Image Fullratio Posted - 2 months ago

$NX debt to equity has declined by 33% year-on-year and by 4.8% since the previous quarter: https://fullratio.com/stocks/nyse-nx/quanex-building-products

User Image phatsuit Posted - 2 months ago

$NX Jump in!

User Image Noah89 Posted - 2 months ago

$SMXT $JBDI $AGX $NX $APLD exploded up by 34% after our ANALYST signaled the entry for our members in the 14-day FREE trial! D!scord link in My profile @Noah89

User Image avicedubois Posted - 2 months ago

$NX Analysts' thoughts for today 👇👇 stock-trading-market.kesug.com/

User Image IN0V8 Posted - 2 months ago

$NX Quanex Building Prods reported quarterly earnings of 73 cents per share which beat the analyst consensus estimate of 70 cents per share. The company reported quarterly sales of $280.300 million which beat the analyst consensus estimate of $278.457 million.

User Image jParkz Posted - 2 months ago

News out $NX Why Quanex Building Products Stock Is Climbing Today https://marketwirenews.com/news-releases/why-quanex-building-products-stock-is-climbing-today-6542524690322268.html $NX

User Image topstockalerts Posted - 2 months ago

Top Gainers PT2 $AGX $BIRD $NX $PALT $RYDE Details: https://topstockalerts.com/market-gainers-and-losers/

User Image topstockalerts Posted - 2 months ago

NNVC announced that it is investigating the potential use of its lead drug candidate NV-387 to treat MPOX patients under the World Health Organization’s Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) protocol. This follows the organization’s recent declaration of a Public Health Emergency due to the 2024 MPOX outbreak. The company, a clinical-stage leader in broad-spectrum antiviral nanomedicines, highlighted that NV-387 has completed Phase 1 clinical trials with no reported adverse events and has demonstrated excellent safety and tolerability. In preclinical studies, NV-387 significantly improved survival rates in animal models of MPOX, showing effectiveness comparable to tecovirimat, the currently approved treatment for smallpox. $LASE $VOR $XPON $NX $SYTA

User Image Stocksrunner Posted - 2 months ago

Top Gainers as Market Opens! 🚀Check out today's top performers lighting up the charts $BENF $AGX $NX $VOR, $SGLY These stocks are soaring as we head into the weekend—keep an eye on them! 📈💥

User Image tradingtwenty Posted - 2 months ago

Top pre-market stock gainers: $WHLR $BLMZ $AGX $FFIE $NX 🔥 Link: https://tradingtwenty.com/dashboard/trending/past

User Image briefingcom Posted - 2 months ago

Gapping up: $AGX +19.4% $BOWL +12.8% $NX +11.7% $FFIE +10.9% $PATH +8.2%

User Image intratio Posted - 2 months ago

$NX https://www.intratio.com/stock-forecast/NX Quanex Building Products CORP The trained model calculated the stock price of this company is not set up well for the near-term and has a neutral long-term outlook

User Image tradingtwenty Posted - 2 months ago

$NX has trended 47 times in the past 24 hours (based on 5 minute intervals). Latest press release on Sep 05, 2024 04:15 PM: Quanex Building Products Announces Third Quarter 2024 Results and Updates Full Year 2024 Guidance Link: https://tradingtwenty.com/news/612881/quanex-building-products-announces-third-quarter-2024-results-and-updates-full-year-2024-guidance

User Image tradingtwenty Posted - 2 months ago

Top 5 after-hours stocks that have trended in the past 24 hours: $VOR 40.61% 🔥 $AGX 24.68% $NX 12.27% $PATH 10.20% $GWRE 8.52% Link: https://tradingtwenty.com/dashboard/trending/past

User Image BULLorSHORT Posted - 2 months ago

$NX Mmm Guidance for 4q an issue

User Image DonCorleone77 Posted - 2 months ago

$NX Quanex raises FY24 revenue view to $1.28B-$1.29B from $1.1B, consensus $1.07B Raises FY24 adjusted EBITDA view to $171M-$176M from $145M-$150M. Wilson commented, "Since we closed on the Tyman acquisition at the beginning of our fourth fiscal quarter, prior guidance for 2024 is no longer valid. While we still feel comfortable with the prior guidance for the legacy Quanex business, we are simply layering in the contribution from the Tyman business for the fourth quarter, which includes the impact related to performing full physical inventory counts at every legacy Tyman location prior to the end of our fiscal year. On a consolidated basis, we now estimate net sales of $1.275 billion to $1.285 billion, which should result in $171 million to $176 million of Adjusted EBITDA* in fiscal 2024."

User Image epsguid Posted - 2 months ago

$NX reported earnings of $0.73, consensus was $0.70 via @eWhispers #epsbeat http://eps.sh/d/nx

User Image DonCorleone77 Posted - 2 months ago

$NX Quanex reports Q3 adjusted EPS 73c, consensus 70c Reports Q3 revenue $280.35M, consensus $278.46M. George Wilson, chairman, president and CEO, stated, "Overall, the results we reported for the third quarter of 2024 were consistent with our expectations. Consistent with the seasonality of our business, volumes increased across all operating segments in the third quarter of this year when compared to the second quarter. However, when compared to the prior year, demand remained soft, but we believe the building products industry will benefit from pent up demand once interest rates start to trend lower and consumer confidence is restored. All things considered, profitability for the quarter was as expected, but due to the decrease in volumes, coupled with lower operating leverage, margins declined year-over-year. Our continued focus on cash flow and managing working capital enabled us to generate approximately $40 million in free cash flow during the quarter."

User Image Stock_Titan Posted - 2 months ago

$NX Quanex Building Products Announces Third Quarter 2024 Results and Updates Full Year 2024 Guidance https://www.stocktitan.net/news/NX/quanex-building-products-announces-third-quarter-2024-results-and-t19qu4x64dtc.html

User Image intratio Posted - 2 months ago

https://www.intratio.com/stock-forecast/NX Quanex Building Products CORP The predictive model has forecasted that the value of this stock has a poor outlook for the near future and has no ground to be a long-term opportunity $NX

User Image intratio Posted - 2 months ago

https://www.intratio.com/stock-forecast/NX Our machine learning model infers this stock s price action will have a short-term downward trend and has no ground to be a long-term opportunity $NX

User Image IN0V8 Posted - 2 months ago

$NX added at $26

User Image intratio Posted - 2 months ago

https://www.intratio.com/stock-forecast/NX Quanex Building Products CORP Our advanced model concludes the value of this equity will not increase any time soon and has no clear long-term directional perspective $NX

User Image intratio Posted - 08/31/24

https://www.intratio.com/stock-forecast/NX Our automated equity analyst is forecasting that the stock price of this company is not likely to rise soon and has a neutral long-term outlook $NX

User Image Stock_Titan Posted - 08/22/24

$NX Quanex Building Products Announces Third Quarter 2024 Earnings Release and Conference Call Schedule https://www.stocktitan.net/news/NX/quanex-building-products-announces-third-quarter-2024-earnings-z9u2w2kc5w10.html

Analyst Ratings
Benchmark Buy Sep 11, 24
Benchmark Buy Apr 23, 24
Benchmark Buy Mar 12, 24
Benchmark Buy Dec 19, 23
Benchmark Buy Sep 6, 23
Benchmark Buy Mar 14, 23
Benchmark Buy Mar 7, 23
Sidoti & Co. Buy May 8, 20
Benchmark Buy Apr 2, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
STEVENS CURTIS M Director Director Jan 04 Sell 30.46 4,880 148,645 5,009 01/05/24
STEVENS CURTIS M Director Director Jan 04 Option 20.02 4,880 97,698 9,889 01/05/24
STEVENS CURTIS M Director Director Sep 05 Option 17.78 5,009 89,060 5,009 09/06/23
GRIFFITHS WILLIAM C Director Director Sep 01 Sell 29.0883 25,000 727,208 135,915 09/06/23
GRIFFITHS WILLIAM C Director Director Jul 18 Sell 28.0338 913 25,595 185,002 07/19/23
Cornett Paul SVP General Counsel,.. SVP General Counsel, Secretary Jan 17 Sell 25 2,000 50,000 37,627 01/18/23
Cornett Paul SVP General Counsel,.. SVP General Counsel, Secretary Jan 17 Option 17.63 2,000 35,260 39,627 01/18/23
DAVIS SUSAN F Director Director Mar 09 Option 19.77 5,987 118,363 5,987 03/10/22
DAVIS SUSAN F Director Director Mar 09 Sell 23.02 5,987 137,821 03/10/22
GRIFFITHS WILLIAM C Executive Chairman Executive Chairman Feb 23 Option 19.45 76,314 1,484,307 268,132 02/23/21
GRIFFITHS WILLIAM C Executive Chairman Executive Chairman Feb 23 Sell 24.56 76,314 1,874,272 233,636 02/23/21
GRIFFITHS WILLIAM C Executive Chairman Executive Chairman Feb 10 Option 18.51 82,118 1,520,004 249,428 02/10/21
GRIFFITHS WILLIAM C Executive Chairman Executive Chairman Feb 10 Sell 24.71 82,118 2,029,136 233,636 02/10/21
Wilson George Laverne President & CEO President & CEO Jan 08 Option 19.37 22,200 430,014 123,678 01/08/21
Wilson George Laverne President & CEO President & CEO Jan 08 Sell 25.07 22,200 556,554 101,478 01/08/21
Wilson George Laverne President & CEO President & CEO Nov 10 Option 15.08 17,600 265,408 83,600 11/10/20
Wilson George Laverne President & CEO President & CEO Nov 10 Sell 20.23 17,600 356,048 74,021 11/10/20
RUPP JOSEPH D Director Director Oct 08 Option 18.02 6,390 115,148 52,300 10/08/20
RUPP JOSEPH D Director Director Oct 08 Sell 19.59 6,390 125,180 45,910 10/08/20